Business Description
Nephros Inc
NAICS : 339112
SIC : 3841
ISIN : US6406713015
Description
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.65 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -1.93 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -13.52 | |||||
| Beneish M-Score | -1.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 34.4 | |||||
| 3-Year EPS without NRI Growth Rate | 35 | |||||
| 3-Year Book Growth Rate | -14.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.42 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.08 | |||||
| 9-Day RSI | 37.21 | |||||
| 14-Day RSI | 41.32 | |||||
| 6-1 Month Momentum % | -30.09 | |||||
| 12-1 Month Momentum % | -51.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.95 | |||||
| Quick Ratio | 4.02 | |||||
| Cash Ratio | 2.32 | |||||
| Days Inventory | 185.63 | |||||
| Days Sales Outstanding | 43.25 | |||||
| Days Payable | 60.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | -4.72 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.04 | |||||
| Operating Margin % | -7.09 | |||||
| Net Margin % | -6.86 | |||||
| FCF Margin % | -15.01 | |||||
| ROE % | -11.26 | |||||
| ROA % | -8.34 | |||||
| ROIC % | -15.71 | |||||
| ROC (Joel Greenblatt) % | -19.99 | |||||
| ROCE % | -9.9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 74.25 | |||||
| PS Ratio | 1.15 | |||||
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 2.28 | |||||
| EV-to-EBIT | -16.48 | |||||
| EV-to-EBITDA | -19.76 | |||||
| EV-to-Revenue | 1.13 | |||||
| EV-to-Forward-Revenue | 0.88 | |||||
| EV-to-FCF | -7.51 | |||||
| Price-to-Median-PS-Value | 0.19 | |||||
| Price-to-Net-Current-Asset-Value | 3.04 | |||||
| Price-to-Net-Cash | 74.5 | |||||
| Earnings Yield (Greenblatt) % | -6.07 | |||||
| FCF Yield % | -12.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NEPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nephros Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.546 | ||
| EPS (TTM) ($) | -0.09 | ||
| Beta | 1.42 | ||
| Volatility % | 68.29 | ||
| 14-Day RSI | 41.32 | ||
| 14-Day ATR ($) | 0.067573 | ||
| 20-Day SMA ($) | 1.565265 | ||
| 12-1 Month Momentum % | -51.13 | ||
| 52-Week Range ($) | 1.3643 - 4.0434 | ||
| Shares Outstanding (Mil) | 10.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nephros Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nephros Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nephros Inc Frequently Asked Questions
What is Nephros Inc(NEPH)'s stock price today?
The current price of NEPH is $1.49. The 52 week high of NEPH is $4.04 and 52 week low is $1.36.
When is next earnings date of Nephros Inc(NEPH)?
The next earnings date of Nephros Inc(NEPH) is 2025-03-07 Est..
Does Nephros Inc(NEPH) pay dividends? If so, how much?
Nephros Inc(NEPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers